Stock Report

All about this stock under one free report Last Updated: 17-May-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All
  • Homearrow
  • Stocksarrow
  • AnPac Bio-Medical Science Co. Ltd. - ADR

AnPac Bio-Medical Science Co. Ltd. - ADR

Stock Card factsheet share-fund-plan-icon

$3.80

up-down-arrow $-36.54 (-90.58%)

As on 21-Jul-2023 09:30EDT

Market cap

info icon

$27 Mln

Revenue (TTM)

info icon

$12 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

5.7

Div. Yield

info icon

0 %

AnPac Bio-Medical Science - ADR Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 3.80 High: 4.10

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $-15 Mln

  • ROEROE information

    -2.4 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -0.1

  • Debt to EquityDebt to Equity information

    -0.9

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    6,273,220

6 Years Aggregate

CFO

CN¥-287.12 Mln

EBITDA

CN¥-433.88 Mln

Net Profit

CN¥-487.01 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
AnPac Bio-Medical Science - ADR
-18.8 2.7 -24.5 -35.4 -67.7 -- --
BSE Sensex*
-11.1 -2.1 -8.9 -7.5 6.6 9.1 11.4
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 21-Jul-2023  |  *As on 15-May-2026  |  #As on 26-Oct-2023
Company
2022
2021
AnPac Bio-Medical Science - ADR
-80.8 -77.0
S&P Small-Cap 600
-17.4 25.3
BSE Sensex
4.4 22.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in (CN¥ Mln)

Annual

*All values are in (CN¥ Mln)

Annual

*All values are in (CN¥ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About AnPac Bio-Medical Science - ADR

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the...  People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is headquartered in Shanghai, the People's Republic of China.  Read more

  • Co-Founder, Co-CEO & Co-Chairman

    Dr. Chris Chang Yu

  • Co-Founder, Co-CEO & Co-Chairman

    Dr. Chris Chang Yu

  • Headquarters

    Lishui

  • Website

    https://www.anpacbio.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for AnPac Bio-Medical Science - ADR

The share price of AnPac Bio-Medical Science Co Ltd - ADR is $3.80 (NASDAQ) as of 21-Jul-2023 09:30 EDT. AnPac Bio-Medical Science Co Ltd - ADR has given a return of -67.67% in the last 3 years.

Since, TTM earnings of AnPac Bio-Medical Science Co Ltd - ADR is negative, P/E ratio is not available.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2022
--
--
2021
--
--
2020
--
--
2019
--
--
2018
--
--

The 52-week high and low of AnPac Bio-Medical Science Co Ltd - ADR are Rs -- and Rs -- as of 17-May-2026.

AnPac Bio-Medical Science Co Ltd - ADR has a market capitalisation of $ 27 Mln as on 21-Jul-2023. As per SEBI classification, it is a Small Cap company.

Before investing in AnPac Bio-Medical Science Co Ltd - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.